La cadena de opciones muestra datos clave de las opciones de acciones de Bluejay Diagnostics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Bluejay Diagnostics..

Bluejay Diagnostics (NASDAQ:BJDX) Bolsa, Cadena de Opciones

Bluejay Diagnostics

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Levi Strauss

News

Pre-Market Outlook

Markets

Movers

AREB

BJDX

CHSN

CVRX

GLXG

GRFX

IPDN

IVDA

KNOP

KPTI

LEVI

PRSU

SOBR

STTK

SVRE

Levi sorprende al mercado con ganancias trimestrales mejores de lo esperado y una perspectiva 2025 que mantiene sin cambios.

Acciones de Levi Strauss suben un 10%; Aquí están 20 acciones que se mueven en el premercado de EE. UU.

Bluejay Diagnostics Inc

<a href="https://x.com/bradlightcap/status/1951389149149405618?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/bradlightcap/status/1951389149149405618?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

MSFT

OpenAI COO Brad Lightcap Posts On X "we have surpassed 5M paying business users on chatgpt, up from 3M in june.we continue to see growth in every segment, from small startups and SMBs to fortune 500. we are working to make it easier for companies of any size to get to implementation and success quickly.."

Earnings

Trump Media & Technology Q2 EPS $(0.08) Up From $(0.10) YoY, Sales $883.30K Up From $836.90K YoY

CIBC analyst Hamir Patel maintains Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) with a Outperformer and raises the price target from $42 to $44.

Price Target

Analyst Ratings

MEOH

CIBC Maintains Outperformer on Methanex, Raises Price Target to $44

CIBC maintains Gildan Activewear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) with a Outperformer and raises the price target from $56 to $60.

CIBC Maintains Outperformer on Gildan Activewear, Raises Price Target to $60

Management

MVST

On July 29, Microvast Holdings  Carl T. Schultz Ceases As CFO

General

NVEE

Kodiak Gas Services Will Replace NV5 Global In The S&P Smallcap 600 Effective Prior To The Opening Of Trading On Wednesday, August 06

CIBC analyst Anita Soni maintains Kinross Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) with a Outperformer and raises the price target from $21 to $22.

CIBC Maintains Outperformer on Kinross Gold, Raises Price Target to $22

Figma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIG#NYSE">FIG</a>) shares traded higher Friday, continuing to draw investor attention after a volatile debut session on Thursday that saw the stock surge over 250% <a href="https://www.benzinga.com/markets/equities/25/08/46785080/jim-cramer-calls-figma-too-expensive-at-50x-sales-stock-surges-250-on-market-debut">following its initial public offering. </a>
What To Know: The stock briefly reached $143.45 in after-hours trading before pulling back.
Figma priced its IPO at $33 per share, raising approximately $1.2 billion and valuing the company at over $19 billion. The offering consisted of nearly 37 million shares and was priced above an already upwardly revised range. Despite sharp gains on day one, Friday&#8217;s trading showed signs of cooling momentum as shares gave up part of their early advance.
Investor interest in Figma is being fueled by strong revenue growth and widespread enterprise adoption. The company reported $749 million in revenue for 2024, up 48% year-over-year and $228.2 million in first-quarter 2025, representing 46% growth from the year prior. Figma counts 95% of Fortune 500 companies and major tech clients such as Microsoft, Alphabet and Salesforce among its customers. It ended 2024 with a net dollar retention rate of 134%.
Still, not everyone is convinced by the valuation. 
CNBC host Jim Cramer repeatedly warned on social media that Figma was "way too expensive," trading at nearly 54 times sales based on a 40% growth rate. He advised investors to avoid placing market orders and predicted a pullback, calling it one of the most expensive stocks in the market.
Despite those warnings, the IPO defied expectations, reinforcing investor appetite for high-growth tech names amid renewed optimism in the broader tech sector. 
Figma's debut follows the collapse of a $20 billion acquisition deal by Adobe, which was scrapped due to regulatory pressure. Now trading independently, Figma has quickly become one of the most closely watched post-IPO stocks, with some market watchers suggesting it could take on meme stock status in the coming weeks.
Friday afternoon, the stock appeared to be stabilizing after its initial surge, trading modestly higher but far below its first-day peak.
FIG Price Action: Figma shares closed Friday up 5.63% at $122, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/08/46805962/trump-russia-medvedev-nuclear-submarines-vix-index-wall-street">Trump Issues Nuclear Threat To Russia–And Wall Street&#8217;s Fear Gauge Goes Vertical</a></li>
</ul>
Image Via Shutterstock.

Figma Shares Edge Higher After Explosive IPO Debut, Despite Valuation Concerns

CIBC analyst Scott Fletcher maintains Colliers International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGI#NASDAQ">CIGI</a>) with a Outperformer and raises the price target from $149 to $175.

CIGI

CIBC Maintains Outperformer on Colliers International Gr, Raises Price Target to $175

NTHI

On July 28, NeOnc Technologies Enters Subscription Agreement With Quazar And Nuromena;  Quazar To Purchase 2,500,000 Nuromena Shares For $400,000;  Co's Holding In Nuromena Reduced To 80%

ABAT

American Battery Technology Says Contract Terminated To Sell Legacy Property In Fernley, Nevada; On July 28, Purchase Agreement Terminated Without Penalties

Canaccord Genuity analyst Jeremy Hoy maintains New Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NGD#TSX">NGD</a>) with a Buy and raises the price target from C$8.25 to C$9.

TSX:NGD

Canaccord Genuity Maintains Buy on New Gold, Raises Price Target to C$9

<a href="https://www.bloomberg.com/news/articles/2025-08-01/apple-ceo-tells-staff-ai-is-ours-to-grab-in-hourlong-pep-talk?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-08-01/apple-ceo-tells-staff-ai-is-ours-to-grab-in-hourlong-pep-talk?embedded-checkout=true</a>

AAPL

'Apple CEO Tells Staff AI Is 'Ours to Grab' in Hourlong Pep Talk'- Bloomberg

BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is set to give its latest quarterly earnings report on Monday, 2025-08-04. Here's what investors need to know before the announcement.
Analysts estimate that BRC will report an earnings per share (EPS) of $-0.03. 
Anticipation surrounds BRC's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.02, leading to a 25.74% drop in the share price the following trading session.
Here's a look at BRC's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.05</td>
<td>-0.02</td>
<td>-0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.04</td>
<td>-0.03</td>
<td>-0.01</td>
<td>-0.01</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-26.0%</td>
<td>-16.0%</td>
<td>4.0%</td>
<td>-38.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1754082431_0.png" alt="eps graph" />
<h3>Market Performance of BRC's Stock</h3>
Shares of BRC were trading at $1.7 as of July 31. Over the last 52-week period, shares are down 67.65%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Observations about BRC</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding BRC.
Analysts have given BRC a total of 3 ratings, with the consensus rating being Outperform. The average one-year price target is $4.0, indicating a potential 135.29% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Hain Celestial Group, Mama's Creations and Laird Superfood, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Hain Celestial Group, with an average 1-year price target of $2.63, suggesting a potential 54.71% upside.</li>
<li>Analysts currently favor an Buy trajectory for Mama's Creations, with an average 1-year price target of $10.0, suggesting a potential 488.24% upside.</li>
<li>Analysts currently favor an Buy trajectory for Laird Superfood, with an average 1-year price target of $12.0, suggesting a potential 605.88% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for Hain Celestial Group, Mama's Creations and Laird Superfood, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>BRC</td>
<td>Outperform</td>
<td>-8.56%</td>
<td>$32.47M</td>
<td>-23.72%</td>
</tr>
<tr>
<td>Hain Celestial Group</td>
<td>Neutral</td>
<td>-10.95%</td>
<td>$84.65M</td>
<td>-17.93%</td>
</tr>
<tr>
<td>Mama's Creations</td>
<td>Buy</td>
<td>18.15%</td>
<td>$9.18M</td>
<td>4.82%</td>
</tr>
<tr>
<td>Laird Superfood</td>
<td>Buy</td>
<td>17.61%</td>
<td>$4.88M</td>
<td>-1.18%</td>
</tr>
</tbody>
</table>

Key Takeaway:
BRC ranks at the bottom for Revenue Growth and Gross Profit among its peers. However, it has the highest Return on Equity. Overall, BRC's performance is mixed compared to its peers, with strengths in profitability but weaknesses in revenue growth.
<h3>All You Need to Know About BRC</h3>
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
<h3>Unraveling the Financial Story of BRC</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: BRC's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -8.56%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: BRC's net margin excels beyond industry benchmarks, reaching -3.21%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): BRC's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -23.72%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): BRC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.28% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 8.92, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/BRCC/earnings">To track all earnings releases for BRC visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRCC

An Overview of BRC's Earnings

<h3>Gainers</h3>
<ul>
<li>ATA Creativity Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) shares rose 46.3% to $1.58 during Friday's after-market session. The company's market cap stands at $69.8 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) shares moved upwards by 15.99% to $0.91. The market value of their outstanding shares is at $4.2 million. </li>
<li>REE Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REE#NASDAQ">REE</a>) stock moved upwards by 7.76% to $0.71. The company's market cap stands at $18.4 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) shares moved upwards by 6.2% to $0.72. The market value of their outstanding shares is at $13.8 million. </li>
<li>Denny's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DENN#NASDAQ">DENN</a>) shares rose 5.65% to $3.8. The market value of their outstanding shares is at $190.6 million. </li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) stock moved upwards by 5.27% to $1.03. The company's market cap stands at $58.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) shares fell 17.3% to $0.41 during Friday's after-market session. The company's market cap stands at $1.9 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock fell 5.91% to $2.71. The company's market cap stands at $2.4 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares declined by 5.2% to $0.51. The market value of their outstanding shares is at $10.4 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares decreased by 4.9% to $4.27. The market value of their outstanding shares is at $18.4 million. </li>
<li>JX Luxventure Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) stock decreased by 3.96% to $0.97. The company's market cap stands at $4.5 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock decreased by 3.94% to $0.98. The company's market cap stands at $12.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AACG

DENN

EZGO

FTEL

GORV

GRWG

LOBO

LXEH

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) shares rose 38.4% to $3.89 during Friday's after-market session. The company's market cap stands at $3.5 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares increased by 28.04% to $0.4. The market value of their outstanding shares is at $2.1 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares rose 21.99% to $8.4. The market value of their outstanding shares is at $45.0 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock rose 10.33% to $0.36. The market value of their outstanding shares is at $14.9 million. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) stock moved upwards by 7.8% to $2.07. The company's market cap stands at $69.0 million. </li>
<li>InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) shares increased by 7.8% to $2.9. The company's market cap stands at $85.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares decreased by 13.9% to $0.39 during Friday's after-market session. The company's market cap stands at $6.8 million. </li>
<li>Equillium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQ#NASDAQ">EQ</a>) stock declined by 8.61% to $0.65. The market value of their outstanding shares is at $13.9 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares declined by 8.51% to $5.7. The market value of their outstanding shares is at $3.4 million. </li>
<li>Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) shares decreased by 8.41% to $49.5. The company's market cap stands at $1.1 billion. </li>
<li>Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) stock fell 7.29% to $4.2. The market value of their outstanding shares is at $202.4 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares declined by 6.85% to $1.36. The company's market cap stands at $7.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADIL

GCTK

NOTV

NSPR

OTRK

PRAX

PRPH

TNON

XCUR

YMAB

12 Health Care Stocks Moving In Friday's After-Market Session

GUIYANG, China, Aug. 1, 2025 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the&nbsp;"Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YMM#NYSE">YMM</a>), a leading digital freight platform, today announced changes to its freight brokerage service.
To ensure sustainability of its freight brokerage service, the Company has decided to increase the service fee rate for freight brokerage service to reduce such service's reliance on government grants and potential uncertainties. The Company understands that such changes may increase costs to shippers. The Company expects that, starting from the quarter ending September 30, 2025, the transaction volume of its freight brokerage service will significantly decline, resulting in a decline in revenue from freight brokerage service, while the cost of revenue for such service will increase, which may adversely affect the Company's profit to certain extent.

Full Truck Alliance To Increase The Service Fee Rate For Freight Brokerage Service

<h3>Gainers</h3>
<ul>
<li>Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) shares moved upwards by 16.3% to $3.36 during Friday's after-market session. The market value of their outstanding shares is at $140.1 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares moved upwards by 8.78% to $0.43. The market value of their outstanding shares is at $3.0 million. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) stock rose 5.29% to $1.79. The market value of their outstanding shares is at $40.0 million. </li>
<li>SKYX Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYX#NASDAQ">SKYX</a>) stock increased by 4.47% to $1.05. The market value of their outstanding shares is at $106.9 million. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) stock rose 4.26% to $0.55. The market value of their outstanding shares is at $8.4 million. </li>
<li>Euro Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLWT#NASDAQ">CLWT</a>) stock increased by 4.09% to $1.27. The company's market cap stands at $9.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) shares fell 7.6% to $0.55 during Friday's after-market session. The company's market cap stands at $10.8 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) shares decreased by 5.67% to $0.45. The company's market cap stands at $8.3 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares declined by 5.41% to $0.05. The market value of their outstanding shares is at $1.6 million. </li>
<li>Tigo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYGO#NASDAQ">TYGO</a>) stock declined by 5.35% to $1.24. The company's market cap stands at $81.8 million. As per the press release, Q2 earnings came out 3 days ago. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock declined by 4.32% to $5.1. The company's market cap stands at $4.5 million. </li>
<li>Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) shares declined by 3.81% to $0.29. The company's market cap stands at $10.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATXG

CLWT

CRGO

HTOO

ILAG

NVVE

RYDE

SKYX

TYGO

WETO

WLGS

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Lantronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) stock rose 10.5% to $3.25 during Friday's after-market session. The market value of their outstanding shares is at $124.8 million. </li>
<li>RingCentral (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) shares rose 6.6% to $25.19. The market value of their outstanding shares is at $2.3 billion. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) shares moved upwards by 5.31% to $4.26. The company's market cap stands at $218.6 million. </li>
<li>Trident Digital Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) stock moved upwards by 4.65% to $1.35. The market value of their outstanding shares is at $94.8 million. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock increased by 4.31% to $1.21. The market value of their outstanding shares is at $4.1 million. </li>
<li>Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) stock moved upwards by 4.0% to $1.3. The market value of their outstanding shares is at $179.8 million. As per the press release, Q2 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>HeartCore Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) shares fell 9.4% to $0.44 during Friday's after-market session. The market value of their outstanding shares is at $11.1 million. </li>
<li>Mega Fortune Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGRT#NASDAQ">MGRT</a>) shares decreased by 5.83% to $3.07. The company's market cap stands at $33.8 million. </li>
<li>Amtech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) shares fell 5.19% to $4.32. The market value of their outstanding shares is at $67.3 million. </li>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) shares decreased by 3.96% to $0.94. The market value of their outstanding shares is at $19.3 million. </li>
<li>Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) stock fell 3.88% to $21.44. The company's market cap stands at $1.0 billion. As per the news, the Q2 earnings report came out 4 days ago. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) shares fell 3.49% to $0.8. The market value of their outstanding shares is at $4.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASYS

BTCS

CETX

HTCR

LTRX

MGRT

PRSO

SQNS

TDTH

UCTT

12 Information Technology Stocks Moving In Friday's After-Market Session

UFP Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) is preparing to release its quarterly earnings on Monday, 2025-08-04. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect UFP Techs to report an earnings per share (EPS) of $2.27.
The announcement from UFP Techs is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.46 in the last quarter, leading to a 0.08% increase in the share price on the following day.
Here's a look at UFP Techs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.01</td>
<td>2.13</td>
<td>1.81</td>
<td>1.53</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.47</td>
<td>2.46</td>
<td>2.39</td>
<td>1.86</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>-10.0%</td>
<td>4.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1754082379_0.png" alt="eps graph" />
<h3>Market Performance of UFP Techs's Stock</h3>
Shares of UFP Techs were trading at $226.39 as of July 31. Over the last 52-week period, shares are down 24.41%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/UFPT/earnings">To track all earnings releases for UFP Techs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

UFPT

What to Expect from UFP Techs's Earnings

Press Releases

Bitech Technologies (OTCQB: BTTC) Appoints Montgomery Bannerman to Drive Strategic Growth in Renewable Energy – see other stocks inside….

Bluejay Diagnostics Announces Reverse Stock Split

Health Care

Financing

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Comments

Bluejay Diagnostics

Bluejay Diagnostics (BJDX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL